Poland - Antivirals for systemic use

Description

1. international chemical name of the medicinal product: Abacavir/LamivudinePower or volume: 600/300 mgCapacity: 600/300 mgFarm: tabletPackage size: 1: 30 pcs.Number of packs: 2.1 Pursuant to § 13 item 1 point 3 of the Regulation of the Minister of Development of 26 July 2016 on types of documents which may be requested by the Contracting Authority from the Economic Operator in a procurement procedure - Journal of Laws of 27 July 2016, item 1126, in connection with the regulation of the Minister of Entrepreneurship and Technology of 16 October 2018 amending the regulation on types of documents that can be demanded by the Contracting Authority from the Contractor in the contract award procedure - Dz.U. of 17 October 2018, item 1993), in order to confirm that the offered supplies meet the requirements specified by the Contracting Authority, the Economic Operator is obliged to confirm with a proper document, i.e. submit with the tender form (subject conditions):- a valid, current permit for marketing within the territory of the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,or - a valid, current permit for marketing issued by the Council of the European Union or the European Commission,Valid, current permit for marketing must be valid on the day of submitting the tenders.Or2.2 The consent of the Minister of Health to import a medicinal product from abroad in accordance with the applicable law - to be presented to the Contracting Authority before signing the contract.2.3 The Orderer allows for the possibility to offer the subject of the contract in foreign language packages. The Contractor must provide at least one instruction in Polish attached to the collective packaging concerning storage and storage of the subject of the order and a copy of consent of the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products for exemption, in whole or in part, from the obligation to prepare the packaging label and package leaflet in Polish. If the above consent is given, the Contracting Authority shall allow it to be delivered before the contract is signed.2.4. The aforementioned documents must have a validity period covering the entire contract execution period.2.5.The documents referred to above shall be submitted in the form of an original electronic document or a copy certified to be a true copy by the Economic Operator using a qualified electronic signature.2.7 Documents drawn up in a foreign language shall be submitted together with a translation into Polish. International, chemical name of the medicinal product: Tenofovir disoproxil | 245 mg | tablet | 30Power or volume: 245 mgFarm size: tabletPack size 30 pcs.Number of packs: 2.1 Pursuant to § 13 item 1 point 3 of the Regulation of the Minister of Development of 26 July 2016 on types of documents which may be requested by the Contracting Authority from the Economic Operator in a procurement procedure - Journal of Laws of 27 July 2016, item 1126, in connection with the regulation of the Minister of Entrepreneurship and Technology of 16 October 2018 amending the regulation on types of documents that can be demanded by the Contracting Authority from the Contractor in the contract award procedure - Dz.U. of 17 October 2018, item 1993), in order to confirm that the offered supplies meet the requirements specified by the Contracting Authority, the Economic Operator is obliged to confirm with a proper document, i.e. submit with the tender form (subject conditions):- a valid, current permit for marketing within the territory of the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,or - a valid, current permit for marketing issued by the Council of the European Union or the European Commission,Valid, current permit for marketing must be valid on the day of submitting the tenders.Or2.2 The consent of the Minister of Health to import a medicinal product from abroad in accordance with the applicable law - to be presented to the Contracting Authority before signing the contract.2.3 The Orderer allows for the possibility to offer the subject of the contract in foreign language packages. The Contractor must provide at least one instruction in Polish attached to the collective packaging concerning storage and storage of the subject of the order and a copy of consent of the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products for exemption, in whole or in part, from the obligation to prepare the packaging label and package leaflet in Polish. If the above consent is given, the Contracting Authority shall allow it to be delivered before the contract is signed.2.4. The aforementioned documents must have a validity period covering the entire contract execution period.2.5.The documents referred to above shall be submitted in the form of an original electronic document or a copy certified to be a true copy by the Economic Operator using a qualified electronic signature.2.7 Documents drawn up in a foreign language shall be submitted together with a translation into Polish. International, chemical name of the medicinal product: Lopinavir/Ritonavir | 200/50 mg | tablet | 120Power or volume: 200/50 mgFarm: tabletPack size 120 pcs.Number of packs: Tender requirements (required permits and/or certificates):2.1. pursuant to § 13 item 1 point 3 of the Regulation of the Minister of Development of 26 July 2016 on types of documents that can be requested by the Contracting Authority from the Economic Operator in a procurement procedure - Journal of Laws of 27 July 2016, item 1126, in connection with the regulation of the Minister of Entrepreneurship and Technology of 16 October 2018 amending the regulation on types of documents that can be demanded by the Contracting Authority from the Contractor in the contract award procedure - Dz.U. of 17 October 2018, item 1993), in order to confirm that the offered supplies meet the requirements specified by the Contracting Authority, the Economic Operator is obliged to confirm with a proper document, i.e. submit with the tender form (subject conditions):- a valid, current permit for marketing within the territory of the Republic of Poland issued by the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products,or - a valid, current permit for marketing issued by the Council of the European Union or the European Commission,Valid, current permit for marketing must be valid on the day of submitting the tenders.Or2.2 The consent of the Minister of Health to import a medicinal product from abroad in accordance with the applicable law - to be presented to the Contracting Authority before signing the contract.2.3 The Orderer allows for the possibility to offer the subject of the contract in foreign language packages. The Contractor must provide at least one instruction in Polish attached to the collective packaging concerning storage and storage of the subject of the order and a copy of consent of the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products for exemption, in whole or in part, from the obligation to prepare the packaging label and package leaflet in Polish. If the above consent is given, the Contracting Authority shall allow it to be delivered before the contract is signed.2.4. The aforementioned documents must have a validity period covering the entire contract execution period.2.5.The documents referred to above shall be submitted in the form of an original electronic document or a copy certified to be a true copy by the Economic Operator using a qualified electronic signature.2.7 Documents drawn up in a foreign language shall be submitted together with a translation into Polish.

Opportunity closing date

10 April 2020

Value of contract

to be confirmed